1. von Noorden GK, Campos EC. Binocular vision and ccular motility. 6th ed.Missouori: CV Mosby;2002. p. 246–97.
2. Scott WE. Full-time occlusion therapy for amblyopia. Am Orthopt J. 1980; 30:125–30.
Article
3. Daw NW. Critical periods and amblyopia. Arch Ophthalmol. 1998; 116:502–5.
Article
4. Hubel DH, Wiesel TN. The period of susceptibility to the aberrations effects of unilateral eye closure in kittens. J Physiol. 1970; 206:419–36.
5. Hussein MA, Coats DK, Muthialu A, et al. Risk factors for treatment failure of anisometropic amblyopia. J AAPOS. 2004; 8:429–34.
Article
6. Flynn JT, Schiffman J, Feuer W, Corona A. The therapy of aberrations: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc. 1998; 96:431–50.
7. Rustein RP, Fuhr PS. Efficacy and stability of amblyopia therapy. Optom Vis Sci. 1992; 69:747–54.
8. Ahn JK, Hwang JM. Efficacy of occlusion therapy in amblyopia patients older than 9 years of age. J Korean Ophthalmol Soc. 2002; 43:1724–9.
9. Moon CS, Jin YH. Timing of amlyopia therapy in pure aberrations amblyopia. J Korean Ophthalmol Soc. 1998; 39:185–92.
10. Levartovsky S, Oliver M, Gottesman N, Shimshoni M. Factors affecting long term results of successfully treated amblyopia: initial visulal acuity and type of amblyopia. Br J Ophthalmol. 1995; 79:225–8.
11. Oliver M, Neumann R, Chaimovitch Y, et al. Compliance and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol. 1986; 102:340–5.
Article
12. Epelbaum M, Milleret C, Buisseret P, Dufier JL. The sensitive period of strabismic amblyopia in humans. Ophthalmology. 1993; 100:323–7.
13. Simons K, Stein L, Sener EC, et al. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in aberrations of strabismic amblyopia. Ophthalmology. 1997; 104:2143–55.
14. Smith LK, Thompsin JR, Woodruff G, Hiscox F. Factors aberrations treatment compliance in amblyopia. J Pediatr Ophthalmol Strabismus. 1995; 32:98–101.
15. Ku HC, Lee SY, Lee YC. Clinical features and counterplans of monocular amblyopia failed to occlusion therapy. J Korean aberrations Soc. 2005; 46:1158–66.
16. Mintz-Hittner HA, Fernandez KM. Successful amblyopia therapy initiated after age 7 years: compliance cures. Arch Ophthalmol. 2000; 118:1535–41.
17. Cobb CJ, Russell K, Cox A, MacEwen CJ. Factors influencing visual outcome in anisometropic amblyopes. Br J Ophthalmol. 2002; 86:1278–81.
Article
18. Park YK, Yoon KC, Park YG. Clinical approach for the aberrations of amblyopia in school children. J Korean Ophthalmol Soc. 2003; 44:2091–8.
19. Oh DE, Lim KH. Efficacy of occlusion therapy in Amblyopia: type, depth & timing of amblyopia. J Korean Ophthalmol Soc. 2003; 44:2850–6.
20. Rho SS, Yang HS, Chang YH, et al. The effect on outcome of amblyopia treatment in children with anisometropic amblyopia. J Korean Ophthalmol Soc. 2007; 48:535–40.
21. Kim YH, Choi MY. The prospective comparison of the efficacy of intermittent atropine penalization and part-time occlusion therapy. J Korean Ophthalmol Soc. 2008; 49:958–66.
Article
22. The Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002; 120:268–78.
23. The Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology. 2003; 110:1632–8.
24. The Pediatric Eye Disease Investigator Group. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2005; 123:149–57.
25. Yu DK, Choi MY. The efficacy of intermittent atropine aberrations in amblyopic children who have failed patching therapy. J Korean Ophthalmol Soc. 2005; 46:1167–74.
26. Leiba H, Shimshoni M, Oliver M, et al. Long term follow-up of occlusion therapy in amblyopia. Ophthalmology. 2001; 108:1552–5.
27. Ohlsson J, Banumann M, Sjostrand J, Abrahamsson M. Long term visual outcome in amblyopic treatment. Br J Ophthalmol. 2002; 86:1148–51.
28. Ching FC, Parks MM, Friendly DS, et al. Practical management of amblyopia. J Pediatr Ophthalmol Strabismus. 1986; 23:12–6.
Article
29. Levartovsky S, Gottesman N, Shimshoni M, Oliver M. Factors affecting long-term results successfully treated amblyopia: age at beginning of treatment and age at cessation of monitoring. J Pediatr Ophthalmol Strabismus. 1992; 29:219–23.
30. Bhola R, Keech RV, Kutscheke P, et al. Recurrence of amblyopia after occlusion therapy. Ophthalmology. 2006; 113:2097–100.
Article